Payment of 2119 shares by Scott Tarriff of Eagle Pharmaceuticals subject to Rule 16b-3
EGRXDelisted Stock | USD 1.99 0.02 1.02% |
Slightly above 62% of Eagle Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Eagle Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. Eagle Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Eagle Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Eagle |
Filed transaction by Eagle Pharmaceuticals Inc executive. Payment of exercise price or tax liability by delivering or withholding securities
Read at macroaxis.com
Eagle Pharmaceuticals Fundamental Analysis
We analyze Eagle Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eagle Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eagle Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Eagle Pharmaceuticals is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Eagle Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eagle Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Eagle Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eagle Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Eagle Pharmaceuticals Related Equities
RGC | Regencell Bioscience | 5.51 | ||||
PBH | Prestige Brand | 0.71 | ||||
AMPH | Amphastar | 0.04 | ||||
COLL | Collegium Pharmaceutical | 0.68 | ||||
EOLS | Evolus | 0.80 | ||||
PAHC | Phibro Animal | 0.93 | ||||
ALKS | Alkermes Plc | 1.02 | ||||
ANIP | ANI Pharmaceuticals | 3.64 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Eagle Pink Sheet
If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |